Product image of Liopcomb (Ezetimibe, Rosuvastatin Zinc) supplied by GNH India

Liopcomb

Active Ingredient:
Ezetimibe, Rosuvastatin Zinc
Origin:
EU

Liopcomb (Ezetimibe, Rosuvastatin Zinc)

Ezetimibe and Rosuvastatin, the active ingredients in Liopcomb, are a combination lipid‑lowering agent presented as a tablet for oral use. It treats primary hypercholesterolemia, mixed dyslipidemia and helps reduce cardiovascular risk in adults.
GNH India supplies Liopcomb as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Egis Pharmaceuticals Plc

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Liopcomb is a fixed‑dose combination that targets lipid abnormalities and cardiovascular risk.
  • Primary hypercholesterolemia: lowers LDL‑C to achieve guideline‑recommended targets.
  • Mixed dyslipidemia: improves overall lipid profile including LDL‑C, triglycerides and HDL‑C.
  • Prevention of cardiovascular events in high‑risk patients: reduces incidence of myocardial infarction, stroke and related complications.

How It Works

  • Ezetimibe blocks the NPC1L1 transporter on intestinal enterocytes, reducing absorption of dietary and biliary cholesterol. Rosuvastatin competitively inhibits HMG‑CoA reductase, the key enzyme in hepatic cholesterol synthesis. The combined actions decrease circulating LDL‑C levels more effectively than either agent alone.

Side Effects

Common Side Effects

  • Headache
  • Abdominal pain
  • Diarrhea
  • Myalgia
  • Nausea
  • Elevated liver enzymes

Serious or Rare Side Effects

  • Rhabdomyolysis or severe myopathy
  • Significant hepatic injury
  • Allergic reactions such as angioedema or Stevens‑Johnson syndrome
  • Severe muscle breakdown with elevated CK
  • Hepatic failure

Precautions & Warnings

  • Before initiating Liopcomb, consider the following precautions.
  • Liver function monitoring: assess baseline and periodic ALT/AST levels.
  • Renal impairment: evaluate kidney function and adjust if severe.
  • Pregnancy and lactation: avoid unless benefits outweigh potential risks.
  • Drug interactions: review concomitant medications, especially CYP3A4 inhibitors.
  • Muscle symptoms: discontinue if severe myopathy occurs.
  • Store at ambient temperature: keep below 25°C, retain in original packaging, protect from moisture.

Avoid Interactions

Liopcomb may interact with several medicines that affect its safety or efficacy.

Major Interactions (Avoid)

  • Strong CYP3A4 inhibitors (e.g., clarithromycin, itraconazole): increase rosuvastatin exposure.
  • Cyclosporine: markedly raises rosuvastatin levels.
  • Gemfibrozil: increased risk of myopathy.

Moderate Interactions (Monitor Closely)

  • Niacin: may increase liver enzyme elevations.
  • Warfarin: may enhance anticoagulant effect; monitor INR.

Frequently Asked Questions

Liopcomb is a fixed‑dose combination of ezetimibe and rosuvastatin indicated for the treatment of primary hypercholesterolemia, mixed dyslipidemia, and for reducing the risk of cardiovascular events in patients considered high‑risk. It is prescribed when diet and lifestyle changes alone are insufficient to reach lipid targets.

Ezetimibe blocks the NPC1L1 transporter in the intestinal brush border, limiting absorption of dietary and biliary cholesterol. Rosuvastatin inhibits HMG‑CoA reductase, the key enzyme in hepatic cholesterol synthesis. Together they lower circulating LDL‑C more effectively than either agent alone.

The specific dose of Liopcomb is determined by the prescribing clinician based on the patient’s lipid profile, cardiovascular risk, and tolerability. Dosage forms and strengths are selected to achieve individualized LDL‑C targets, and adjustments are made during follow‑up.

The safety of Liopcomb in pregnancy or lactation has not been established. It should be used only if the potential benefit justifies the potential risk to the fetus or infant, and a healthcare professional should evaluate the situation before prescribing.

To request Liopcomb, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with statin monotherapy, Li

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ezetimibe, Rosuvastatin Zinc

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT